Bath & Body Works, Inc. $BBWI Shares Sold by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. reduced its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 60.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 48,000 shares of the company’s stock after selling 72,200 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Bath & Body Works were worth $896,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in BBWI. Geneos Wealth Management Inc. grew its holdings in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares in the last quarter. Danske Bank A S bought a new position in shares of Bath & Body Works during the third quarter worth about $39,000. Global Retirement Partners LLC bought a new position in shares of Bath & Body Works during the fourth quarter worth about $31,000. Activest Wealth Management acquired a new position in Bath & Body Works in the fourth quarter worth about $32,000. Finally, Advisory Services Network LLC acquired a new position in Bath & Body Works in the third quarter worth about $48,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

NYSE:BBWI opened at $21.09 on Friday. The firm has a market capitalization of $4.25 billion, a P/E ratio of 5.92, a P/E/G ratio of 2.04 and a beta of 1.38. The business has a 50 day simple moving average of $19.63 and a 200 day simple moving average of $20.45. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $33.67.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same period last year, the company earned $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts anticipate that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, June 5th were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date of this dividend was Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on BBWI shares. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. UBS Group decreased their target price on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. The Goldman Sachs Group downgraded Bath & Body Works from a “neutral” rating to a “sell” rating and lowered their price target for the company from $23.00 to $19.00 in a report on Wednesday, July 8th. Weiss Ratings raised Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Finally, Piper Sandler began coverage on Bath & Body Works in a research note on Friday, May 15th. They set a “neutral” rating and a $20.00 price objective on the stock. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Bath & Body Works currently has an average rating of “Hold” and a consensus price target of $22.00.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.